TARA DAVIS: Open Payments
NPI 1821118530 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,283 in 125 payments from 13 companies in 2025. Trend: 2023 $3,074 · 2024 $2,270 · 2025 $2,283
Food & beverage: $2,172Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $448 |
| Alkermes, Inc. | 17 | $344 |
| Teva Pharmaceuticals USA, Inc. | 13 | $270 |
| Lundbeck LLC | 12 | $234 |
| Otsuka America Pharmaceutical, Inc. | 13 | $222 |
| Vanda Pharmaceuticals Inc. | 8 | $165 |
| ABBVIE INC. | 15 | $156 |
| Axsome Therapeutics, Inc. | 8 | $144 |
| Novo Nordisk Inc | 1 | $83 |
| Supernus Pharmaceuticals, Inc. | 4 | $68 |
Products named: CAPLYTA, REXULTI, ARISTADA, ABILIFY MAINTENA, FANAPT, VRAYLAR, Auvelity, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
